Lipid lowering, particularly with HMG-CoA-reductase inhibitors (statins) has been progressively validated for secondary prevention of MI.
Search
Apr 05, 20251 min read
Lipid lowering, particularly with HMG-CoA-reductase inhibitors (statins) has been progressively validated for secondary prevention of MI.